ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Candel Therapeutics Inc

Candel Therapeutics Inc (CADL)

9.80
2.05
(26.45%)
At close: December 12 3:00PM
7.7201
-2.08
( -21.22% )
After Hours: 4:54PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
7.7201
Bid
7.72
Ask
7.84
Volume
29,436,996
7.9092 Day's Range 10.82
1.00 52 Week Range 14.60
Market Cap
Previous Close
7.75
Open
7.93
Last Trade
20
@
7.79
Last Trade Time
16:54:06
Financial Volume
US$ 288,387,523
VWAP
9.7968
Average Volume (3m)
2,066,830
Shares Outstanding
32,475,537
Dividend Yield
-
PE Ratio
-8.40
Earnings Per Share (EPS)
-1.17
Revenue
-
Net Profit
-37.94M

About Candel Therapeutics Inc

Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies. Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Candel Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CADL. The last closing price for Candel Therapeutics was US$7.75. Over the last year, Candel Therapeutics shares have traded in a share price range of US$ 1.00 to US$ 14.60.

Candel Therapeutics currently has 32,475,537 shares outstanding. The market capitalization of Candel Therapeutics is US$251.69 million. Candel Therapeutics has a price to earnings ratio (PE ratio) of -8.40.

CADL Latest News

Candel Therapeutics Announces $80 Million Proposed Public Offering

NEEDHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (“Candel”) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological...

Candel Therapeutics Announces CAN-2409 Achieved Primary Endpoint in Phase 3 Prostate Cancer Trial, Showing Significantly Improved Disease-Free Survival

Positive topline data for CAN-2409 viral immunotherapy achieved primary endpoint by demonstrating statistically significant and clinically meaningful benefit when combined with radiation therapy...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
13.357976.97721333274.362214.64.28204945177.67024839CS
43.560185.57932692314.1614.63.78558695787.4204428CS
12-0.2799-3.49875814.63.78520668307.30126203CS
26-0.0499-0.6422136422147.7714.63.78511546217.12084296CS
526.3751473.9851301121.34514.6121460476.50270536CS
156-1.0699-12.17178612068.7914.60.667390346.39992496CS
260-0.2799-3.49875814.780.666674286.44833083CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TFFPTFF Pharmaceuticals Inc
US$ 0.1049
(61.38%)
7.44M
AVLDirexion Daily AVGO Bull 2X Shares
US$ 29.25
(29.37%)
99.68k
TRUGTruGolf Holdings Inc
US$ 0.6701
(29.14%)
4.93M
SPISPI Energy Company Ltd
US$ 0.4493
(28.37%)
6.21M
AVGXDefiance Daily Target 2X Long AVGO ETF
US$ 27.53
(28.23%)
498.87k
RPTXRepare Therapeutics Inc
US$ 2.53
(-36.27%)
883.55k
INOInovio Pharmaceuticals Inc New
US$ 3.02
(-19.68%)
266.07k
CADLCandel Therapeutics Inc
US$ 7.90
(-19.39%)
1.6M
AVSDirexion Daily AVGO Bear 1X Shares
US$ 21.65
(-13.96%)
17.52k
SLGLSol Gel Technologies Ltd
US$ 0.4436
(-11.26%)
5.02k
AVGOBroadcom Inc
US$ 206.50
(14.30%)
9.7M
TFFPTFF Pharmaceuticals Inc
US$ 0.1049
(61.38%)
7.44M
SPISPI Energy Company Ltd
US$ 0.4493
(28.37%)
6.21M
TRUGTruGolf Holdings Inc
US$ 0.6701
(29.14%)
4.93M
GOEVCanoo Inc
US$ 0.1684
(-3.77%)
4.83M

CADL Discussion

View Posts
Monksdream Monksdream 3 hours ago
The stock isn’t going to zero
👍️0
PonkenPlonken PonkenPlonken 4 hours ago
My problem is that I dont have a feeling for when that is most relevant.
👍️0
Monksdream Monksdream 4 hours ago
Short positions do represent potential buying power
👍️ 1
PonkenPlonken PonkenPlonken 4 hours ago
I always interpet them as to-be-buyers too.
👍️0
Monksdream Monksdream 5 hours ago
It happens with these biomed stocks after a press release
👍️0
PonkenPlonken PonkenPlonken 5 hours ago
And a lot of shares still sold short
👍️0
Monksdream Monksdream 6 hours ago
Apparently professional asset managers did take a liking to this stock
👍️ 1
Invest-in-America Invest-in-America 7 hours ago
CADL: No Sir!!! I simply WISH we had some legitimate "SCIENCE" somewhere on this Planet --- primarily in HEALTH CARE, MEDICINE, LIFE EXTENSION, GENOMICS, etc.
👍️0
PonkenPlonken PonkenPlonken 7 hours ago
You are one of these anti-science people?
👍️0
PonkenPlonken PonkenPlonken 8 hours ago
go go
👍️0
Invest-in-America Invest-in-America 22 hours ago
CADL: If you SCORED some nice bucks behind this fluff news, well, CONGRATS to ya, Dude!!! That's ALL you can do with this "Health Science" crap!!! NEVER hold this MEDICAL junk long!!! Not even during ONE day of their bogus PR's. The simple fact that every hospital on this moronic Planet has a GERIATRICS DEPARTMENT is dispositive PROOF that this Planet has NO FUCKING KNOWLEDGE WHATSOEVER ABOUT ANY ASPECT OF HUMAN PHYSIOLOGY!!!!! Lastly, there's another Department in every hospital on this mindless Planet --- for which, however, said hospitals do not even display SIGNAGE --- but it is called, THE CEMETERY DEPARTMENT!!! And we ALL eventually go there!!! Even every one of the stupid DOCTORS, NURSES, & TECHNICIANS who are employed in those "Hospitals"!!! (Have ya finally learned the TRUTH about "Medical Science" today, fella??? And from a fellow iHuber!!!)
👍️0
PonkenPlonken PonkenPlonken 24 hours ago
will be used in all cancers with nestin overexpression eventually
👍️0
PonkenPlonken PonkenPlonken 1 day ago
See who commented on the stock before today. I even commented last night. I think its fair to say i had conviction.
You guys are late to the party then tell me how bad their science is after the fact ... with the stock up 180% in the morning?
GL with that
👍️0
Invest-in-America Invest-in-America 1 day ago
--------------------------------
👍️0
Invest-in-America Invest-in-America 1 day ago
CADL: I know this stuff, you don't.

"Immunotherapy drugs like Candel's teach the immune system to find and destroy cancer cells. The drug helped 75.2% of patients with intermediate-to-high risk localized prostate cancer live for 54 months without any sign of cancer. In comparison, just 65.7% of the radiation-only group met the same bar."

If you think such PETTY differences in such 'studies' is significant, you are just plain IGNORANT!! I paltry 10% difference???!!!
👍️0
PonkenPlonken PonkenPlonken 1 day ago
Meet primary endpoint ph3 = fluff news
lol
What would be a PR of substance? Scientists turn lead into gold? Or breed the golden goose?
👍️0
Invest-in-America Invest-in-America 1 day ago
CADL: So much for such Phase-3 Medical BULLSHIT --- mere STATISTICAL ARTIFACTS --- so-called 'history-making' (baloney) "news" about Prostate Cancer!!! (The worst "Cancer" on this reprobate Planet is the MEDICAL IGNORANCE of the "Doctors" & "Researchers" THEMSELVES!!!!)
👍️0
Monksdream Monksdream 1 day ago
LOST roughly half the market cap from the session high
Will professional asset managers take a liking to it
👍️0
axelvento axelvento 1 day ago
https://www.biospace.com/press-releases/candel-therapeutics-announces-can-2409-achieved-primary-endpoint-in-phase-3-prostate-cancer-trial-showing-significantly-improved-disease-free-survival
👍️0
Invest-in-America Invest-in-America 1 day ago
CADL: One's BANK ACCT. might end of "PROSTRATE", if they invest in this FLUFF NEWS firm!! They have NOTHING at all to fix PROSTATE Cancer --- mere STATISTICAL ARTIFACTS resultant from their useless "clinical studies". (The only reason the PRICE of this stock might soar today is because Homo sapiens generally are frickin' IGNORANT of the truth behind the pathetic stupidity of so-called "Medical Science" on this Planet, Bro!! If Mankind KNEW anything at all about the Human genome or otherwise physiology, your beloved Son would be alive today!! I'm an Atheist, but I do hope your Son is now sitting at the right hand of JESUS, or something, Bro!!)

PS: Nevertheless, if you bought this one, CONGRATS if you score MONSTER TIME!!!
👍️0
TheFinalCD TheFinalCD 1 day ago
you mean Prostate 🙃
👍️0
tw0122 tw0122 1 day ago
Prostrate phase 3 rules $12.34 + 166% 
👍️0
PonkenPlonken PonkenPlonken 1 day ago
They will make you feel like wood in the ocean then zoom it up in 1 go.
Easy to argue with people hard to argue with data/physics!
👍️0
PonkenPlonken PonkenPlonken 1 day ago
hehe there it is
sold 33% 10s .............. and some 12s
👍️0
PonkenPlonken PonkenPlonken 4 days ago
background https://www.fiercebiotech.com/biotech/ex-gsk-immunology-chief-takes-over-oncolytic-virus-biotech-candel-as-it-ramps-up-its
👍️0
PonkenPlonken PonkenPlonken 5 days ago
Cured GBM in patient....
Paul Peter Tak, the make-it-happen-man, parachuted in to bring this awesome platform to life. Watching closely... with the readouts in early 2025. Might run in anticipation soon.
👍️0
PonkenPlonken PonkenPlonken 5 days ago
Cured GBM in patient....
Paul Peter Tak, the make-it-happen-man, parachuted in to bring this awesome platform to life. Watching closely... with the readouts in early 2025. Might run in anticipation soon.
👍️0
PonkenPlonken PonkenPlonken 3 weeks ago
mustve done pretty well at the jefferies conference
👍️0
PonkenPlonken PonkenPlonken 3 weeks ago
violently undervalued still.... what i dont know is whether the stock will go up in the near term.
👍️0
falcon21 falcon21 1 month ago
this stock is the laughing stock what I'm I missing anyone else feel that way
👍️0
falcon21 falcon21 1 month ago
this stock is the laughing stock what I'm I missing anyone else feel that way
👍️0
PonkenPlonken PonkenPlonken 1 month ago
I love the CEO - was at Flagship and Chief Immunology Officer at GSK. Parachuted in to finish the job.

The panc data was the best i have ever seen.... You rarely read about such a 36 month surival here. 47% -- atleast the rest of the market was equally surprised their appoach works.
Eventually CAN3110 will be used in all cancers that express nectin
👍️0
PonkenPlonken PonkenPlonken 1 month ago
https://x.com/paulpetertak/status/1850866975515259299
👍️0
falcon21 falcon21 1 month ago
why so quiet on this board great stock no news
👍️0
PonkenPlonken PonkenPlonken 2 months ago
good opportunity prior to the readouts
👍️0
TechandBio TechandBio 3 months ago
Candel yearly range is.60 range to $15.00 low to high if you find cancer stocks that are disruptive big gains potential. I see similar potential with ICCM IceCure kills breast cancer and Lung cancer with 97% non recurrence rate 5 years out. No outstanding debt or warrants.

ICCM
https://d1io3yog0oux5.cloudfront.net/_bc04737bc474935b6b12dfea965ac04e/icecuremedical/db/2291/21959/pdf/IceCure+Medical+%28ICCM%29+Company+Presentation+-+29-Aug-2024+FINAL.pdf

https://www.prnewswire.com/news-releases/icecure-medical-reports-final-ice3-breast-cancer-cryoablation-trial-results-of-100-patient-and-physician-satisfaction-and-96-3-recurrence-free-rate-data-submitted-to-fda-requesting-marketing-authorization-to-treat-early-stage-b-302116526.html


$CADL
👍️0
Monksdream Monksdream 3 months ago
CADL under $7
👍️0
Monksdream Monksdream 3 months ago
CADL under $7
👍️0
Monksdream Monksdream 4 months ago
CADL 10Q due AUGUST 19
👍️0
Monksdream Monksdream 4 months ago
CADL 10Q due MONDAY AUGUST 12
👍️0
Monksdream Monksdream 5 months ago
CADL under $7
👍️0
TechandBio TechandBio 5 months ago
Cancer Killing Platforms. Candel and IceCure. I only bought a 5000 shares of $CADL at .88 sold half at 9.00 riding 2500 shares.. I'm accumulating shares of IceCure Literally has a cure rate for early breast cancer patients with a success rate at 97% with 5 year independent follow up DATA . Even more impressive is the late stage breast cancer data just came out with a year follow up with 92.5% success rate treating tumors twice the size as the ones treated in the early breast cancer patients. Cryoblast is seeing amazing results in Lung, Liver and Kidney Cancer. approved in 15 countries including Brazil, China and many EU countries. Insurance companies are on board and patients are using the technology in the USA but have to pay out of pocket until FDA approval. The minimally invasive medical space is growing companies like $PLSE went from 50 million market to a Billion in the last two years Pulse Biosciences and IceCure $ICCM have very cutting edge technology with better quicker results than surgery with procedures being done with local anesthetic in a in a doctors office being able to go home with in a few hours pretty remarkable. IceCure will see tremendous growth and one of the Richest families in Asia the Lee family Victor Lee an a early invester in Tencent owns 52% of IceCure shares.
$CADL.
👍️0
PonkenPlonken PonkenPlonken 5 months ago
Remember them buying up 450k shares a second after the readout was released on May23 all the way into high 16s.
sooner or later, the data will speak again and everyone will have to listen to whats being said.
👍️0
Monksdream Monksdream 5 months ago
CADL under $10
👍️0
falcon21 falcon21 7 months ago
added at 7.50 today
👍️0
falcon21 falcon21 7 months ago
only 1.5 mil short
👍️0
glenn1919 glenn1919 7 months ago
CADL................................a/h...................$$$$$$$$$$$$$$$$$$$$$$$$$$$
👍️0
Monksdream Monksdream 7 months ago
CADL under $10
Months
👍️0
skidoo31 skidoo31 8 months ago
Short squeeze coming soon, mm have been borrowing my shares.
👍️0
PonkenPlonken PonkenPlonken 8 months ago
agree. mcap should be 1bln $+++.
institutions are waiting on the bid- then do the lifting on liquidity event.

LOTS of retail antihero-themed traders are short. Weak line of defense.
👍️0

Your Recent History

Delayed Upgrade Clock